Also called: Desmopressin Acetate, Desmoda (desmopressin acetate)
Desmopressin is a man-made copy of a natural body chemical called vasopressin. Vasopressin tells the kidneys to hold onto water instead of making urine. Doctors give desmopressin to people whose bodies don't make enough of this chemical on their own. When a person takes desmopressin, their kidneys keep more water in the body.
This means they make less urine and don't feel as thirsty. In one study, three people taking desmopressin were able to use smaller amounts after starting a different kind of diabetes medicine. The medicine changed how their bodies handled salt and water, so less desmopressin was needed to keep them feeling well. Scientists are still learning about how desmopressin works together with other medicines.
Taking too much can make the body hold too much water, which can be dangerous. Anyone using desmopressin needs a doctor to watch their dose carefully. More research with more people is needed to confirm how these medicines affect each other.
Benefits
The benefits people report — backed by research.
You just read the research on Desmopressin. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Adverse effects reported in the research and by community use.
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Timeline
Key moments in Desmopressin’s research and regulatory timeline — sourced and dated.
News
Dated, sourced reporting that mentions Desmopressin.
The foundation recaps the 2020 Ferring recall of intranasal desmopressin (DDAVP/Stimate) for superpotency and notes that in June 2022 the company said the nasal spray would not be available until mid-2024 at the earliest. It lists practical alternatives for patients with von Willebrand disease and mild hemophilia A: STAQ Pharma's DDAVP nasal spray (distributing since September 2021), tranexamic acid or aminocaproic acid, IV or subcutaneous DDAVP, and factor replacement for severe cases.
Ferring Pharmaceuticals US voluntarily recalled all marketed lots of DDAVP Nasal Spray, Desmopressin Acetate Nasal Spray and STIMATE Nasal Spray nationwide to the consumer level after routine stability testing found the products were superpotent. FDA's notice states the risk of excess desmopressin is abnormally low blood sodium (hyponatremia), which could eventually lead to seizure, coma, and death. One non-fatal adverse event potentially associated with the issue had been reported in the US.
Wondering how Desmopressin pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →Compare
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.